Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Brain Tumors and Neurologic Cancers

The focus of the Vanderbilt Brain Tumor Center is to provide comprehensive compassionate care to patients with brain tumors. We have assembled a dedicated team of clinicians and scientists who are committed to finding a cure for brain cancer. We are passionate in this pursuit.

Clinical Trials for Neurologic / Brain Cancers

7 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Diagnostic

VICCNEU1268

05/01/2012

Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers

Treatment

VICCNEU13107

06/13/2014

A Phase II Study of Rindopepimut/GM-CSF in Patients with Relapsed EGFRvIII-Positive Glioblastoma

Treatment

VICCMD1403

06/02/2014

An Open Label, Phase II Study of Neratinib in Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification

Treatment

VICCMEL1398

05/23/2014

BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation- Positive Melanoma that has Metastasized to the Brain

Treatment

COGACNS1022

06/09/2012

ACNS1022 - A Phase II Randomized Trial of Lenalidomide (NSC# 703813, InD# 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

Treatment

COGACNS0831

05/12/2011

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years.

Treatment

VICCRAD1060

02/15/2011

A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients with 1-4 Brain Metastases